Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-70.78%Cash Return on Invested Capital
VS
Market
Sector
Industry
History
$ 2.18Close
$ 1.01 - $ 6.6 52-Week Range
Ticker Information
Ticker
PHIOCompany Name
PHIO PHARMACEUTICALS CORPSector
HealthcareIndustry
BiotechnologyExchange
NASDAQPHIO PHARMACEUTICALS CORP - Cash Return on Invested Capital Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
PHIO - CROIC Historical data
| Date | Cash Return on Invested Capital | Free Cash Flow | Invested Capital |
|---|---|---|---|
| 6/30/2025 | -70.78% | $ -7.14M | $ 10.1M |
| 3/31/2025 | -52.42% | $ -6.38M | $ 12.17M |
| 12/31/2024 | -150.6% | $ -7.11M | $ 4.72M |
| 9/30/2024 | -163.99% | $ -8.11M | $ 4.95M |
| 6/30/2024 | -240.07% | $ -9.06M | $ 3.77M |
| 3/31/2024 | -179.46% | $ -10.06M | $ 5.6M |
| 12/31/2023 | -138.49% | $ -10.75M | $ 7.76M |
| 9/30/2023 | -152.26% | $ -11.09M | $ 7.28M |
| 6/30/2023 | -117.13% | $ -11.72M | $ 10.01M |
| 3/31/2023 | -152.84% | $ -11.38M | $ 7.45M |
Key Performance Insights, Last 5 Years
- PHIO PHARMACEUTICALS CORP's latest trailing twelve months (TTM) CROIC stands at -54.2%.
- Over the past 5 years, PHIO PHARMACEUTICALS CORP's average CROIC has been -101.73%.
- The median CROIC for PHIO PHARMACEUTICALS CORP during this period was -79.15%
- PHIO PHARMACEUTICALS CORP reached its highest CROIC over the past 5 years at -30.44%.
- The lowest CROIC recorded by PHIO PHARMACEUTICALS CORP in the same timeframe -240.07%
Similar metrics to Inv. Capital:
- Return on Invested Capital - [Calculation] Return on Invested Capital (ROIC) measures how well a company allocates its invested capital to profitable projects and/or investments. It is calculated as net income [NetIncCmn] divided by invested capital [InvCapital].
- Invested Capital - [Calculation] Invested Capital is the total amount of money raised by a business in the form [Equity] and/or [Debt].
- Capital Expenditures to Operating Cash Flow - [Calculation] The CapEx to Operating Cash Flow ratio, measures how much of a company’s operating cash flow is reinvested into productive [Assets]. It is capital expenditures [CapEx] divided by net operating cash flow [NCFO].
- Capital Expenditures Margin - [Calculation] The CapEx Margin, also named Capex to Revenue Ratio, measures how much of a company’s revenue is reinvested into productive [Assets]. It is capital expenditures [CapEx] divided by [Revenue].
- Price to Free Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].
Definition of Cash Return on Invested Capital
[Calculation] Cash Return on Invested Capital (CROIC) measures how well a company uses its invested capital to produce cash. It is calculated as Free Cash Flow [FCF] divided by invested capital [InvCapital].FCF / Inv. Capital
(=) CROIC CROIC for PHIO PHARMACEUTICALS CORP is calculated as follows: FCF [ $ -8.74M ] / Inv. Capital [ $ 16.12M ]
(=) CROIC [ -54.2% ] PHIO - Cash Return on Invested Capital, Last 5 years
-240.07%
Minimum
Jun 30, 2024
-30.44%
Maximum
Mar 31, 2021
-101.73%
Average
-79.15%
Median
CROIC Benchmark AnalysisMarket
The chart above depicts the distribution of CROIC for companies in the Total Stock Market. The average CROIC of the companies is 2.84% with a standard deviation of 15.02%.
The following table provides additional summary stats:
CROIC in the Market:
| filtered constituents | 3.46K |
|---|---|
| min | -43.78% |
| max | 49.57% |
| average | 2.84% |
| median | 5.02% |
| std | 15.02% |